| Value | ₹0.02 Cr |
|---|
BSE filing, NSE: QUESS. Summary written from the filing by ALFA Finder's alert engine.
Quess Corp Ltd: key numbers
- Share price
- ₹318.60
- Market cap
- ₹4,759 Cr
- Revenue (annual)
- ₹15,305 Cr
- Net profit (annual)
- ₹221.6 Cr
- P/E (TTM)
- 17.3×Sector 23.5×
- Promoter holding
- 56.81%-0.01% QoQ
- FII holding
- 10.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quess Corp Ltd
All →Quess Corp Earnings Call Transcript: Key Takeaways
Quess Corp reported 15% revenue growth driven by record general staffing additions, though EBITDA margins remained thin at 2.1%. Management is pivoting toward higher-margin 'Quest 2.0' segments to improve profitability.
Quess Corp Dividend
QUESS CORP LIMITED's board meeting held 30 Oct 2026 approved an interim dividend of Rs.5 per share for FY 2026-27. Record date is 6 November 2026 and payment is due by 20 November 2026.
Quess Corp Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹4,396 Cr (+15% YoY), Adj. EBITDA ₹92 Cr (+20%), PAT ₹75 Cr (+44%). Positioning as tech-enabled workforce platform with global scale ambitions.
Quess Corp Results Update
Quess Corp's Q2 FY27 press release shows PAT up 44% YoY to ₹75 crore on revenue of ₹4,396 crore. It also flags a ₹5 interim dividend.
Quess Corp Q2 FY27 Results: Net Profit ₹74.7 Cr, Up 44.2% YoY
Quess Corp Ltd reported revenue from operations of ₹4,396 Cr (+14.7% YoY) and net profit of ₹74.7 Cr (+44.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.7 Cr · +44.2% YoY
Quess Corp Board Meeting Date
Quess Corp Ltd intimated that its Board meeting is scheduled for 30 October 2026 to consider Q1/H1 FY27 results and an interim dividend. No decision has been taken yet; the agenda items are proposed only.
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.